BRIEF published on 11/10/2025 at 21:55, 2 months 24 days ago Integrated BioPharma publie ses résultats financiers pour le troisième trimestre 2025 Résultats Financiers Baisse Des Revenus Résultat D'exploitation Revenu Net Fabrication Sous Contrat
BRIEF published on 11/10/2025 at 21:55, 2 months 24 days ago Integrated BioPharma Reports Financial Results for Q3 2025 Financial Results Net Income Revenue Decline Operating Income Contract Manufacturing
PRESS RELEASE published on 11/10/2025 at 21:50, 2 months 24 days ago Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2025 Integrated BioPharma, Inc. reports financial results for the quarter ended September 30, 2025, with $12.7 million revenue and insights on operating income and net income Financial Results Revenue Net Income Operating Income Integrated BioPharma
BRIEF published on 09/23/2025 at 21:45, 4 months 11 days ago Integrated BioPharma Reports Fiscal Year 2025 Results Financial Results Revenue Growth Net Income Operating Income Contract Manufacturing
BRIEF published on 09/23/2025 at 21:45, 4 months 11 days ago Integrated BioPharma publie ses résultats pour l'exercice 2025 Résultats Financiers Croissance Des Revenus Résultat D'exploitation Revenu Net Fabrication Sous Contrat
PRESS RELEASE published on 09/23/2025 at 21:40, 4 months 11 days ago Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2025 Integrated BioPharma, Inc. reports 11.8% increase in revenue for Q2 2025. Operating income rises in Q2 & FY 2025. Net loss in Q2 but net income grows for FY 2025 Revenue Increase Net Income Net Loss Operating Income Integrated BioPharma
BRIEF published on 05/14/2025 at 21:35, 8 months 21 days ago Integrated BioPharma, Inc. publie ses résultats financiers pour le premier trimestre 2025 Résultats Financiers Croissance Des Revenus Résultat D'exploitation T1 2025 Principaux Clients
BRIEF published on 05/14/2025 at 21:35, 8 months 21 days ago Integrated BioPharma, Inc. Posts Financial Results for Q1 2025 Financial Results Revenue Growth Operating Income Q1 2025 Key Customers
PRESS RELEASE published on 05/14/2025 at 21:30, 8 months 21 days ago Integrated BioPharma Reports Results for its Quarter Ended March 31, 2025 Integrated BioPharma, Inc. reports a 6.1% revenue increase for Q1 2025 compared to Q1 2024. Company had operating income and net income growth. Key focus on core business and expanding customer base Financial Results Revenue Increase Net Income Operating Income Integrated BioPharma
BRIEF published on 02/13/2025 at 22:00, 11 months 19 days ago Integrated BioPharma Reports Quarterly Results with Increased Revenue Revenue Growth Q4 Results Operating Income Customer Base Expansion Integrated BioPharma
Published on 02/05/2026 at 17:35, 23 minutes ago Pentagon I Capital Corp. Enters into Letter Agreement to Complete Qualifying Transaction with Prospectiva Resources Ltd.
Published on 02/05/2026 at 16:40, 1 hour 18 minutes ago Relevant Gold Appoints Larry Taddei to Board of Directors and Mal Karwowska as Strategic Advisor
Published on 02/05/2026 at 15:45, 2 hours 13 minutes ago American Critical Minerals Recaps a Highly Successful 6 Months and Files Amended and Restated Technical Report
Published on 02/05/2026 at 15:10, 2 hours 48 minutes ago Electric Metals (USA) Limited Announces Change of Auditor
Published on 02/05/2026 at 14:50, 3 hours 8 minutes ago High Tide Resources Announces Non-Brokered Private Placements
Published on 02/05/2026 at 17:40, 18 minutes ago BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 01.02.26.
Published on 02/05/2026 at 17:40, 18 minutes ago UV GERMI : MISE À DISPOSITION DE LA NOTE D’INFORMATION ET DU DOCUMENT « AUTRES INFORMATIONS » DANS LE CADRE DE L’OFFRE PUBLIQUE DE RACHAT D’ACTIONS INITIÉE PAR UV GERMI
Published on 02/05/2026 at 17:05, 52 minutes ago European Research and Innovation: the Politecnico di Milano Launches an Office in Brussels
Published on 02/05/2026 at 16:20, 1 hour 37 minutes ago Original-Research: Deutsche Rohstoff AG (von First Berlin Equity Research GmbH): Buy
Published on 02/05/2026 at 17:35, 23 minutes ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
